Evaluation of a pharmacist-run antiarrhythmic clinic in an ambulatory practice.
| Autor: | Lifer SM, Musser MR, Kier KL |
|---|---|
| Jazyk: | angličtina |
| Zdroj: | Journal of the American Pharmacists Association : JAPhA [J Am Pharm Assoc (2003)] 2015 Sep-Oct; Vol. 55 (5), pp. 546-51. |
| DOI: | 10.1331/JAPhA.2015.14260 |
| Abstrakt: | Objective: To describe the impact of a pharmacist-run antiarrhythmic clinic in an outpatient practice. Setting: Blanchard Valley Medical Associates (BVMA) in Findlay, OH. Practice Description: BVMA is a 15-physician private practice with five pharmacists on staff who run several disease management clinics. Practice Innovation: Patients receiving amiodarone or sotalol are referred to a pharmacist-run antiarrhythmic clinic within an outpatient physicians' office. The pharmacist is responsible for coordinating, monitoring, and reviewing results with patients. Evaluation: A retrospective chart review was conducted to compare adherence to monitoring protocols between patients referred to the pharmacist-run clinic and patients managed solely by physicians, and to evaluate the type and frequency of pharmacist-initiated interventions. Patients had received antiarrhythmic treatment for at least 6 months before the beginning of the retrospective review. Results: A total of 130 patient charts were reviewed. Adherence for each recommended testing parameter for patients on amiodarone and sotalol was significantly higher among patients managed by a pharmacist, compared with usual care. A total of 62 adverse events were detected, and 39 interventions were made by the pharmacist group. Conclusion: Patients with pharmacist monitoring of outpatient antiarrhythmic medications had greater adherence to recommended testing protocols compared with usual care. |
| Databáze: | MEDLINE |
| Externí odkaz: |
|